Oligodendroglial maldevelopment in the cerebellum after postnatal hyperoxia and its prevention by minocycline

GLIA

Volumn 63, Issue 10, 2015, Pages 1825-1839

  Scheuer, Till ^a,b   Brockmöller, Vivien ^a   Blanco Knowlton, Marissa ^c   Weitkamp, Jörn Hendrik ^c   Ruhwedel, Torben ^d   Mueller, Susanne ^a   Endesfelder, Stefanie ^a   Bührer, Christoph ^a   Schmitz, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c VANDERBILT UNIVERSITY   (United States)

^d MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Cerebellum; Hyperoxia; Minocycline; Oligodendroglia; Preterm infants; White matter damage

Indexed keywords

3 NITROTYROSINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN 18; MINOCYCLINE; MYELIN BASIC PROTEIN; PLATELET DERIVED GROWTH FACTOR A; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; NERVE PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CEREBELLAR GLIAL DAMAGE; CEREBELLUM INJURY; CONTROLLED STUDY; HYPEROXIA; IMMUNOHISTOCHEMISTRY; INFANT; MACROGLIA; MICROGLIA; MYELIN SHEATH; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; OXIDATIVE STRESS; OXYGEN CONCENTRATION; PERINATAL PERIOD; POSTNATAL HYPEROXIA; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WHITE MATTER INJURY; YOUNG ADULT; AGE; ANIMAL; CELL COMMUNICATION; CELL CULTURE; CELL DEATH; CEREBELLUM; DISEASE MODEL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MAMMALIAN EMBRYO; METABOLISM; NEWBORN; PATHOLOGY; PREVENTION AND CONTROL; SPRAGUE DAWLEY RAT; STEM CELL; ULTRASTRUCTURE; WISTAR RAT;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL COMMUNICATION; CELL DEATH; CELL PROLIFERATION; CELLS, CULTURED; CEREBELLUM; CYTOKINES; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; HYPEROXIA; MINOCYCLINE; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; STEM CELLS;

EID: 84938955709     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22847     Document Type: Article

References (79)

1. Arvin KL, Han BH, Du Y, Lin S, Paul SM, Holtzman DM. 2002. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 52:54-61.
2. Ashwell K. 1991. The distribution of microglia and cell death in the fetal rat forebrain. Brain Res Dev Brain Res 58:1-12.
3. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. 1998. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 18:6241-6253.
4. Back SA, Miller SP. 2014. Brain injury in premature neonates: A primary cerebral dysmaturation disorder? Ann Neurol 75:469-486.
5. Back SA, Rosenberg PA. 2014. Pathophysiology of glia in perinatal white matter injury. Glia 62:1790-1815.
6. Bannerman P, Hahn A, Soulika A, Gallo V, Pleasure D. 2007. Astrogliosis in EAE spinal cord: Derivation from radial glia, and relationships to oligodendroglia. Glia 55:57-64.
7. Baud O, Haynes RF, Wang H, Folkerth RD, Li J, Volpe JJ, Rosenberg PA. 2004. Developmental up-regulation of MnSOD in rat oligodendrocytes confers protection against oxidative injury. Eur J Neurosci 20:29-40.
8. Baumann N, Pham-Dinh D. 2001. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871-927.
9. Benn T, Halfpenny C, Scolding N. 2001. Glial cells as targets for cytotoxic immune mediators. Glia 36:200-211.
10. Besnard F, Perraud F, Sensenbrenner M, Labourdette G. 1987. Platelet-derived growth factor is a mitogen for glial but not for neuronal rat brain cells in vitro. Neurosci Lett 73:287-292.
11. Cai Z, Lin S, Fan L-W, Pang Y, Rhodes PG. 2006. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 137:425-435.
12. Cai Z-Y, Yan Y, Chen R. 2010. Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model. Neurosci Bull 26:28-36.
13. Castillo A, Sola A, Baquero H, Neira F, Alvis R, Deulofeut R, Critz A. 2008. Pulse oxygen saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive care unit: Is 85% to 93% an acceptable range? Pediatrics 121:882-889.
14. Clemente D, Ortega MC, Melero-Jerez C, de Castro F. 2013. The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases. Front Cell Neurosci 7:268.
15. Constable RT, Ment LR, Vohr BR, Kesler SR, Fulbright RK, Lacadie C, Delancy S, Katz KH, Schneider KC, Schafer RJ, Makuch RW, Reiss AR. 2008. Prematurely born children demonstrate white matter microstructural differences at 12 years of age, relative to term control subjects: An investigation of group and gender effects. Pediatrics 121:306-316.
16. Curtis R, Cohen J, Fok-Seang J, Hanley MR, Gregson NA, Reynolds R, Wilkin GP. 1988. Development of macroglial cells in rat cerebellum. I. Use of antibodies to follow early in vivo development and migration of oligodendrocytes. J Neurocytol 17:43-54.
17. Dammann O, Leviton A. 2004. Inflammatory brain damage in preterm newborns-Dry numbers, wet lab, and causal inferences. Early Hum Dev 79:1-15.
18. Defaux A, Zurich M-G, Honegger P, Monnet-Tschudi F. 2011. Minocycline promotes remyelination in aggregating rat brain cell cultures after interferon-γ plus lipopolysaccharide-induced demyelination. Neuroscience 187:84-92.
19. De Kieviet JF, Piek JP, Aarnoudse-Moens CS, Oosterlaan J. 2009. Motor development in very preterm and very low-birth-weight children from birth to adolescence: A meta-analysis. JAMA 302:2235-2242.
20. Deulofeut R, Dudell G, Sola A. 2007. Treatment-by-gender effect when aiming to avoid hyperoxia in preterm infants in the NICU. Acta Paediatr 96:990-994.
21. Diguet E, Fernagut P-O, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F. 2004. Deleterious effects of minocycline in animal models of parkinson's disease and huntington's disease. Eur J Neurosci 19:3266-3276.
22. Di Penta A, Moreno B, Reix S, Fernandez-Diez B, Villanueva M, Errea O, Escala N, Vandenbroeck K, Comella JX, Villoslada P. 2013. Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS One 8:e54722.
23. Emery B. 2010. Regulation of oligodendrocyte differentiation and myelination. Science 330:779-782.
24. Endesfelder S, Zaak I, Weichelt U, Bührer C, Schmitz T. 2013. Caffeine protects neuronal cells against injury caused by hyperoxia in the immature brain. Free Radic Biol Med C 67:221-234.
25. Fagel DM, Ganat Y, Silbereis J, Ebbitt T, Stewart W, Zhang H, Ment LR, Vaccarino FM. 2006. Cortical neurogenesis enhanced by chronic perinatal hypoxia. Exp Neurol 199:77-91.
26. Fan L-W, Pang Y, Lin S, Tien L-T, Ma T, Rhodes PG, Cai Z. 2005. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J Neurosci Res 82:71-82.
27. Fatemi SH, Folsom TD, Reutiman TJ, Thuras PD. 2009. Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum 8:64-69.
28. Favrais G, van de Looij Y, Fleiss B, Ramanantsoa N, Bonnin P, Stoltenburg-Didinger G, Lacaud A, Saliba E, Dammann O, Gallego J, Sizonenko S, Hagberg H, Lelièvre V, Gressens P. 2011. Systemic inflammation disrupts the developmental program of white matter. Ann Neurol 70:550-565.
29. Felderhoff-Mueser U, Bittigau P, Sifringer M, Jarosz B, Korobowicz E, Mahler L, Piening T, Moysich A, Grune T, Thor F, Heumann R, Bührer C, Ikonomidou C. 2004. Oxygen causes cell death in the developing brain. Neurobiol Dis 17:273-282.
30. Folkerth RD. 2006. Periventricular leukomalacia: Overview and recent findings. Pediatr Dev Pathol 9:3-13.
31. Fruttiger M, Karlsson L, Hall AC, Abramsson A, Calver AR, Boström H, Willetts K, Bertold CH, Heath JK, Betsholtz C, Richardson WD. 1999. Defective oligodendrocyte development and severe hypomyelination in PDGF-a knockout mice. Development 126:457-467.
32. Funa K, Sasahara M. 2014. The roles of PDGF in development and during neurogenesis in the normal and diseased nervous system. J Neuroimmune Pharmacol 9:168-181.
33. Gallo V, Armstrong RC. 1995. Developmental and growth factor-induced regulation of nestin in oligodendrocyte lineage cells. J Neurosci 15:394-406.
34. Gallo V, Zhou JM, McBain CJ, Wright P, Knutson PL, Armstrong RC. 1996. Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block. J Neurosci 16:2659-2670.
35. Gard AL, Burrell MR, Pfeiffer SE, Rudge JS, Williams WC. 1995. Astroglial control of oligodendrocyte survival mediated by PDGF and leukemia inhibitory factor-like protein. Development 121:2187-2197.
36. Gerstner B, Bührer C, Rheinländer C, Polley O, Schüller A, Berns M, Obladen M, Felderhoff-Mueser U. 2006. Maturation-dependent oligodendrocyte apoptosis caused by hyperoxia. J Neurosci Res 84:306-315.
37. Gerstner B, Sifringer M, Dzietko M, Schüller A, Lee J, Simons S, Obladen M, Volpe JJ, Rosenberg PA, Felderhoff-Mueser U. 2007. Estradiol attenuates hyperoxia-induced cell death in the developing white matter. Ann Neurol 61:562-573.
38. Haldipur P, Bharti U, Alberti C, Sarkar C, Gulati G, Iyengar S, Gressens P, Mani S. 2011. Preterm delivery disrupts the developmental program of the cerebellum. PLoS One 6:e23449.
39. Hill RA, Patel KD, Medved J, Reiss AM, Nishiyama A. 2013. NG2 cells in white matter but not gray matter proliferate in response to PDGF. J Neurosci 33:14558-14566.
40. Ivanov I, Murrough JW, Bansal R, Hao X, Peterson BS. 2014. Cerebellar morphology and the effects of stimulant medications in youths with attention deficit-hyperactivity disorder. Neuropsychopharmacology 39:718-726.
41. Karlsson U, Schultz RL. 1965. Fixation of the central nervous system from electron microscopy by aldehyde perfusion. I. Preservation with aldehyde perfusates versus direct perfusion with osmium tetroxide with special reference to membranes and the extracellular space. J Ultrastruct Res 12:160-186.
42. Kettenmann H, Hanisch U-K, Noda M, Verkhratsky A. 2011. Physiology of microglia. Physiol Rev 91:461-553.
43. Kinney HC. 2005. Human myelination and perinatal white matter disorders. J Neurol Sci 228:190-192.
44. Larroque B, Ancel P-Y, Marret S, Marchand L, André M, Arnaud C, Pierrat V, Rozé J-C, Messer J, Thiriez G, Burguet A, Picaud J-C, Bréart G, Kaminski M; EPIPAGE Study Group. 2008. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): A longitudinal cohort study. Lancet 371:813-820.
45. Leviton A, Allred E, Kuban KCK, Dammann O, O'Shea TM, Hirtz D, Schreiber MD, Paneth N; ELGAN Study Investigators 2010. Early blood gas abnormalities and the preterm brain. Am J Epidemiol 172:907-916.
46. Limperopoulos C, Chilingaryan G, Guizard N, Robertson RL, Du Plessis AJ. 2010. Cerebellar injury in the premature infant is associated with impaired growth of specific cerebral regions. Pediatr Res 68:145-150.
47. Limperopoulos C, Soul JS, Gauvreau K, Huppi PS, Warfield SK, Bassan H, Robertson RL, Volpe JJ, du Plessis AJ. 2005. Late gestation cerebellar growth is rapid and impeded by premature birth. Pediatrics 115:688-695.
48. -ΔΔCT Method. Methods 25:402-408.
49. Maki T, Liang AC, Miyamoto N, Lo EH, Arai K. 2013. Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases. Front Cell Neurosci 7:275.
50. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
51. Miller SP, Ferriero DM, Leonard C, Piecuch R, Glidden DV, Partridge JC, Perez M, Mukherjee P, Vigneron DB, Barkovich AJ. 2005. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr 147:609-616.
52. Möbius W, Cooper B, Kaufmann WA, Imig C, Ruhwedel T, Snaidero N, Saab AS, Varoqueaux F. 2010. Electron microscopy of the mouse central nervous system. Methods Cell Biol 96:475-512.
53. Northam GB, Liégeois F, Chong WK, Wyatt JS, Baldeweg T. 2011. Total brain white matter is a major determinant of IQ in adolescents born preterm. Ann Neurol 69:702-711.
54. Pang Y, Cai Z, Rhodes PG. 2005. Effect of tumor necrosis factor-alpha on developing optic nerve oligodendrocytes in culture. J Neurosci Res 80:226-234.
55. Pang Y, Zheng B, Fan L-W, Rhodes PG, Cai Z. 2007. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/akt and interruption of the mitochondrial apoptotic pathway. Glia 55:1099-1107.
56. Parker J, Mitchell A, Kalpakidou A, Walshe M, Jung H-Y, Nosarti C, Santosh P, Rifkin L, Wyatt J, Murray RM, Allin M. 2008. Cerebellar growth and behavioural & neuropsychological outcome in preterm adolescents. Brain 131:1344-1351.
57. Pinato L, da Silveira Cruz-Machado S, Franco DG, Campos LMG, Cecon E, Fernandes PACM, Bittencourt JC, Markus RP. 2013. Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesis. Brain Struct Funct.
58. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD. 1988. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333:562-565.
59. Reynolds R, Wilkin GP. 1988. Development of macroglial cells in rat cerebellum. II. An in situ immunohistochemical study of oligodendroglial lineage from precursor to mature myelinating cell. Development 102:409-425.
60. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M. 1988. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53:309-319.
61. Ritter J, Schmitz T, Chew L-J, Bührer C, Möbius W, Zonouzi M, Gallo V. 2013. Neonatal hyperoxia exposure disrupts axon-oligodendrocyte integrity in the subcortical white matter. J Neurosci 33:8990-9002.
62. Riva D, Giorgi C. 2000. The cerebellum contributes to higher functions during development: Evidence from a series of children surgically treated for posterior fossa tumours. Brain 123 (Part 5):1051-1061.
63. Sawada K, Saito S, Horiuchi-Hirose M, Mori Y, Yoshioka Y, Murase K. 2013. Dose-related cerebellar abnormality in rats with prenatal exposure to X-irradiation by magnetic resonance imaging volumetric analysis. Congenit Anom (Kyoto) 53:127-130.
64. Schmitz T, Krabbe G, Weikert G, Scheuer T, Matheus F, Wang Y, Mueller S, Kettenmann H, Matyash V, Bührer C, Endesfelder S. 2014. Minocycline protects the immature white matter against hyperoxia. Exp Neurol 254:153-165.
65. Schmitz T, Ritter J, Mueller S, Felderhoff-Mueser U, Chew L-J, Gallo V. 2011. Cellular changes underlying hyperoxia-induced delay of white matter development. J Neurosci 31:4327-4344.
66. Spittle AJ, Doyle LW, Anderson PJ, Inder TE, Lee KJ, Boyd RN, Cheong JLY. 2010. Reduced cerebellar diameter in very preterm infants with abnormal general movements. Early Hum Dev 86:1-5.
67. Steinlin M. 2008. Cerebellar disorders in childhood: Cognitive problems. Cerebellum 7:607-610.
68. Stoodley CJ, Schmahmann JD. 2009. Functional topography in the human cerebellum: A meta-analysis of neuroimaging studies. Neuroimage 44:489-501.
69. Stoodley CJ, Valera EM, Schmahmann JD. 2012. Functional topography of the cerebellum for motor and cognitive tasks: An fMRI study. Neuroimage 59:1560-1570.
70. Tang M, Alexander H, Clark RSB, Kochanek PM, Kagan VE, Bayir H. 2010. Minocycline reduces neuronal death and attenuates microglial response after pediatric asphyxial cardiac arrest. J Cereb Blood Flow Metab 30:119-129.
71. Tsuji M, Wilson MA, Lange MS, Johnston MV. 2004. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 189:58-65.
72. Ueno M, Fujita Y, Tanaka T, Nakamura Y, Kikuta J, Ishii M, Yamashita T. 2013. Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci 16:543-551.
73. Volpe JJ. 2009. Cerebellum of the premature infant: Rapidly developing, vulnerable, clinically important. J Child Neurol 24:1085-1104.
74. Vottier G, Pham H, Pansiot J, Biran V, Gressens P, Charriaut-Marlangue C, Baud O. 2011. Deleterious effect of hyperoxia at birth on white matter damage in the newborn rat. Dev Neurosci 33:261-269.
75. Wang SS-H, Kloth AD, Badura A. 2014. The cerebellum, sensitive periods, and autism. Neuron 83:518-532.
76. Wierzba-Bobrowicz T, Kosno-Kruszewska E, Gwiazda E, Lechowicz W. 1998. The comparison of microglia maturation in different structures of the human nervous system. Folia Neuropathol 36:152-160.
77. Wilson HC, Onischke C, Raine CS. 2003. Human oligodendrocyte precursor cells in vitro: Phenotypic analysis and differential response to growth factors. Glia 44:153-165.
78. Xue M, Mikliaeva EI, Casha S, Zygun D, Demchuk A, Yong VW. 2010. Improving outcomes of neuroprotection by minocycline: Guides from cell culture and intracerebral hemorrhage in mice. Am J Pathol 176:1193-1202.
79. Yan H, Rivkees SA. 2006. Hypoglycemia influences oligodendrocyte development and myelin formation. Neuroreport 17:55-59.